Synuclein-alpha(Phospho Ser129) Polyclonal Antibody

Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Alternatively spliced transcripts encoding different isoforms have been identified for this gene.

Introducing the SYNUCLEIN-ALPHA(PHOSPHO SER129) POLYCLONAL ANTIBODY, a cutting-edge product designed to revolutionize the field of molecular biology. This meticulously crafted antibody is specifically engineered to target the phosphorylated serine 129 residue of the synuclein-alpha protein, offering unparalleled accuracy and sensitivity in detecting and quantifying this crucial biomarker.

With its polyclonal nature, this antibody exhibits exceptional affinity and specificity, ensuring reliable and reproducible results in a wide range of applications. Its high binding capacity enables precise identification and localization of synuclein-alpha (phospho Ser129) in various biological samples, facilitating comprehensive investigations into the role of this protein in neurodegenerative disorders such as Parkinson's disease.

The SYNUCLEIN-ALPHA(PHOSPHO SER129) POLYCLONAL ANTIBODY boasts exceptional versatility, making it an indispensable tool for researchers and scientists alike. Its compatibility with diverse experimental techniques, including immunohistochemistry, immunofluorescence, and Western blotting, allows for comprehensive characterization of synuclein-alpha (phospho Ser129) in both in vitro and in vivo settings.

Furthermore, this antibody is meticulously manufactured using state-of-the-art techniques, ensuring batch-to-batch consistency and reliability. Rigorous quality control measures guarantee the utmost purity and functionality of each vial, providing researchers with the confidence to pursue groundbreaking discoveries with utmost precision.

In summary, the SYNUCLEIN-ALPHA(PHOSPHO SER129) POLYCLONAL ANTIBODY represents a breakthrough in molecular biology research. Its exceptional specificity, versatility, and reliability make it an indispensable tool for unraveling the intricate mechanisms underlying neurodegenerative disorders. Embrace this cutting-edge antibody and unlock new frontiers in scientific exploration.